1. Home
  2. COUR vs XNCR Comparison

COUR vs XNCR Comparison

Compare COUR & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$5.85

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$12.04

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COUR
XNCR
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
881.9M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
COUR
XNCR
Price
$5.85
$12.04
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$11.07
$22.89
AVG Volume (30 Days)
4.2M
706.2K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
39.22
65.36
EPS
N/A
N/A
Revenue
$757,500,000.00
$125,576,000.00
Revenue This Year
$9.34
N/A
Revenue Next Year
$6.60
$11.88
P/E Ratio
N/A
N/A
Revenue Growth
9.04
13.65
52 Week Low
$5.47
$6.92
52 Week High
$13.56
$18.69

Technical Indicators

Market Signals
Indicator
COUR
XNCR
Relative Strength Index (RSI) 40.70 47.56
Support Level $5.47 $10.92
Resistance Level $6.38 $12.87
Average True Range (ATR) 0.27 0.71
MACD -0.02 0.04
Stochastic Oscillator 7.91 49.37

Price Performance

Historical Comparison
COUR
XNCR

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: